库珀医疗CooperCompanies（COO）2026财年第一季度业绩报告「NYSE」（英文版）（9页）.pdf

1、PRESS RELEASECooperCompanies Announces First Quarter 2026 ResultsSAN RAMON,Calif.,March 05,2026(GLOBE NEWSWIRE)-CooperCompanies(Nasdaq:COO),a leadingglobal medical device company,today announced financial results for its fiscal first quarter ended January 31,2026.First quarter 2026 revenue of$1.024

2、billion,up 6%,or up 3%organically,from last years first quarter.First quarter 2026 GAAP diluted earnings per share(EPS)of$0.66,up$0.14 or 27%from last yearsfirst quarter.First quarter 2026 Non-GAAP diluted EPS of$1.10,up$0.18 or 20%from last years first quarter.SeeReconciliation of Selected GAAP Res

3、ults to Non-GAAP Results below.Were pleased to report a strong start to the fiscal year,highlighted by product launches,outstandingprofitability,and robust cash flow,all of which gives us the confidence to raise both earnings and free cash flowguidance.Revenue growth benefited from continued strengt

4、h in our premium MyDay portfolio,and momentumis building from product launches including early traction from MyDay MiSight.Operating margins exceededexpectations,reflecting disciplined execution and the meaningful synergies delivered through last yearsreorganization.These improvements are strengthen

5、ing our foundation-enhancing efficiency,improving our coststructure,and enabling more targeted investment in our highest-return opportunities,said Al White,CooperCompanies President and CEO.Our strong free cash flow also supported ongoing share repurchases,which remain a core element of ourcapital-a

6、llocation strategy.Combined with improved organizational alignment and progress across our keyinitiatives,we believe we are well positioned to build momentum as the year progresses.Importantly,we remainon track with our long-term outlook for generating more than$2.2 billion in free cash flow from 20